UC Davis MIND Institute Distinguished Lecturer Series features renowned neuroscientist Karl Deisseroth
February 8, 2016
Neuroscientist Karl Deisseroth, the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University, will discuss “Illuminating the Brain in Health and Disease” during the next UC Davis MIND Institute Distinguished Lecturer Series presentation on Wednesday, Feb. 10, at 4:30 p.m.
January 13, 2016
UC Davis’ leadership in Huntington’s disease research received another boost recently when Kyle Fink, a post-doctoral fellow at the Institute for Regenerative Cures, was recognized by the American Academy of Neurology (AAN) for the cutting-edge research findings in gene editing that he presented at the 2015 Society for Neuroscience Annual Meeting.
December 30, 2015
Jonathan Kipnis, director of the Center for Brain Immunology and Glia (BIG) at the University of Virginia, will discuss “The Brain’s Lymphatic System and Behavior” during the next UC Davis MIND Institute Distinguished Lecturer Series presentation on Wednesday, Jan. 13, at 4:30 p.m.
UC Davis Alzheimer's Disease Center Caregiver's Workshop to Address Having Alzheimer's Disease with Dignity
October 23, 2015
Jason Karlawish, professor of medicine, medical ethics and health policy at the University of Pennsylvania, will offer his insights on “Having Alzheimer’s Disease with Dignity” during the 2015 UC Davis Alzheimer’s Disease Center Community Engagement Series Lecture on Saturday, Nov. 7, from 8 a.m. to 12:30 p.m. in the auditorium of the UC Davis MIND Institute, 2825 50th St., Sacramento.
October 6, 2015
A UC Davis research team has been awarded $15.5 million to build the world’s first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation’s leading edge of molecular imaging.
October 6, 2015
Monique Breteler, director of Population Health Sciences at the German Center for Neurodegenerative Diseases, will address “What You Can Do to Prevent Alzheimer’s Disease,” during the October UC Davis Alzheimer’s Disease Center 2015 Distinguished Lecture.
October 5, 2015
Concussions — occurring from impacts to the head on the sports field, battlefield, or in an automobile or other accident — are the subject of a two-hour event featuring a multidisciplinary group of UC Davis physicians conducting leading-edge research to identify and treat traumatic brain injuries (TBI) and their long-term aftermath, dementia.
September 21, 2015
Ricardo A. Maselli, UC Davis professor of neurology, has received a $300,000 grant from the Muscular Dystrophy Association to test the use of stem cells as a vehicle for delivering ColQ, which is a protein that is deficient in a severe form of Congenital Myasthenic Syndrome.
September 14, 2015
Vitamin D insufficiency among the elderly is highly correlated with accelerated cognitive decline and impaired performance, particularly in domains such as memory loss that are associated with Alzheimer’s disease and dementia, researchers with the UC Davis Alzheimer’s Disease Center and Rutgers University have found. [en español] [中文 Chinese]
UC Davis researchers receive $5.4 million grant to study new tool to evaluate early-stage Alzheimer's
August 31, 2015
Alzheimer’s researchers at UC Davis and UC San Diego have launched a new study which aims to detect the earliest stages of cognitive dysfunction in people with pre-clinical Alzheimer’s disease by using event-related brain potentials (ERPs).
August 18, 2015
Hardy souls from the UC Davis Multidisciplinary ALS Clinic will take up the cause to raise funds for the ALS Association on Wednesday, Aug. 19, during the ALS ice-bucket challenge — a dousing with ice-cold water that is a call to action to donate to a cure for ALS.
July 29, 2015
Cardiologists at UC Davis are the first in Northern California to treat the major risk of stroke that comes with atrial fibrillation (AF), the most common form of arrhythmia, with a device that blocks blood clots from traveling from the heart to the head.
July 21, 2015
UC Davis medical Center has again ranked as one of the best hospitals in the U.S. for 2015-16 in 10 adult medical specialties by U.S. News & World Report.
July 16, 2015
Imaging the brain, collecting clinical measurements and biological specimens, and generating an unprecedented volume of data for more than 1,700 participants, the groundbreaking Alzheimer's Disease Neuroimaging Initiative (ADNI) has painted a detailed picture of the brain’s progression from cognitive impairment to Alzheimer’s disease, often over many years, demonstrating that while amyloid brain deposits are a leading factor in dementia, there is considerable heterogeneity in cognitive decline in aging.
July 14, 2015
Falls, the leading cause of non-fatal and fatal injuries and a leading cause of death among the elderly, will be the topic of the July UC Davis Alzheimer’s Disease Center Community Discovery Series lecture. The speaker will be Christy Adams, UC Davis Health System Trauma Prevention and Outreach Program coordinator.
July 9, 2015
Michael Rogawski, professor of neurology at UC Davis, recently was awarded the 2015 Neuroendocrine Research Award at the 67th Annual American Academy of Neurology meeting in Washington, D.C.
June 24, 2015
UC Davis is stimulating innovative, collaborative brain research with a new program offering funding for projects with strong potential to lead to impactful discoveries.
May 12, 2015
Surgeons at UC Davis Health System are testing an innovative method of limiting cognitive decline in patients with Parkinson’s disease. The treatment — deep brain stimulation, or DBS — involves delivering low levels of electrical stimulation to a part of the brain that controls the abilities to think, plan and remember.
May 11, 2015
On April 15, 2015, three UC Davis leaders in research joined more than forty scientists from across the University of California (UC) system and representatives from the biomedical industry to discuss plans for strengthening UC’s position in drug, device and diagnostics development.
April 27, 2015
UC Davis investigators have settled a long-standing controversy surrounding the molecular basis of an inherited disorder that historically affected Ashkenazi Jews from Eastern Europe but now also arises in other populations of Semitic descent, particularly families from Saudi Arabia.
April 16, 2015
The UC Davis Alzheimer's Disease Center, one of only 27 research centers designated by the National Institutes of Health's National Institute on Aging, has established a new clinic in the East Bay in Walnut Creek.
April 15, 2015
David A. Bennett, director of the Rush University Alzheimer's Disease Center, will discuss "Reducing Your Risk for Alzheimer's Disease: Building a Better Brain as We Age," during the May UC Davis Alzheimer's Disease Center Community Engagement Lecture Series presentation.
March 26, 2015
UC Davis will establish a prestigious, leading-edge center to advance innovative research into the origins of schizophrenia: A Silvio O. Conte Center for Basic or Translational Mental-Health Research, one of only 15 such centers in the United States.
Alzheimer's Disease Center lecture explores connections between diabetes, heart disease and dementia
March 18, 2015
"Heart Disease, Diabetes and Dementia, What is the Connection?" will be the topic of the UC Davis Alzheimer's Disease Center 2015 Community Discovery lecture by center Associate Director Bruce Reed.
Commentary says study affirms that varied factors contribute to cognitive decline throughout adulthood
March 16, 2015
A study published online today in JAMA Neurology that finds associations between reduced hippocampal volume (HVa) and being male, but not the gene APOE ɛ4, suggests that there are multiple factors contributing to cognitive decline throughout adulthood, according to an accompanying commentary by UC Davis Alzheimer's Disease Center Director Charles DeCarli.
March 3, 2015
Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells – responsible for a usually fatal type of brain cancer – and could be applicable to other highly aggressive cancers.